Cargando…

The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study

PURPOSE: Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not macimorelin, stimulated copeptin secretion (a surrogate marker of vasopressin) and, therefore, provide nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Atila, Cihan, Monnerat, Sophie, Urwyler, Sandrine Andrea, Refardt, Julie, Winzeler, Bettina, Christ-Crain, Mirjam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345811/
https://www.ncbi.nlm.nih.gov/pubmed/35723775
http://dx.doi.org/10.1007/s11102-022-01240-0
_version_ 1784761514302898176
author Atila, Cihan
Monnerat, Sophie
Urwyler, Sandrine Andrea
Refardt, Julie
Winzeler, Bettina
Christ-Crain, Mirjam
author_facet Atila, Cihan
Monnerat, Sophie
Urwyler, Sandrine Andrea
Refardt, Julie
Winzeler, Bettina
Christ-Crain, Mirjam
author_sort Atila, Cihan
collection PubMed
description PURPOSE: Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not macimorelin, stimulated copeptin secretion (a surrogate marker of vasopressin) and, therefore, provide novel tests to assess the posterior pituitary. The exact underlying mechanism behind their stimulatory effect remains elusive. METHODS: This analysis combined data from three diagnostic studies conducted at the University Hospital Basel, Switzerland. In total, 80 healthy adults underwent the glucagon (n = 22), arginine (n = 30), or macimorelin (n = 28) stimulation tests. The primary objective was to investigate glucose course upon glucagon, arginine, and macimorelin stimulation tests and its effect on plasma copeptin release. RESULTS: Upon glucagon stimulation, the median [IQR] glucose level at baseline was 5.0 [4.6, 5.2] mmol/l, peaked at 8.1 [7.2, 9.4] mmol/l after 30 min and decreased to a minimum of 3.8 [3.5, 4.5] mmol/l after 120 min. The median copeptin increase upon glucagon stimulation was 7.7 [2.6, 28.0] pmol/l. Upon arginine, the glucose level at baseline was 4.9 [4.8, 5.5] mmol/l, peaked at 6.0 [5.2, 6.4] mmol/l after 30 min and decreased to a minimum of 4.3 [3.8, 4.8] mmol/l after 60 min. The median copeptin increase upon arginine stimulation was 4.5 [2.9, 7.5] pmol/l. Upon macimorelin, glucose levels showed no notable dynamics over the 120 min, and no major change in copeptin was observed. In the pooled dataset, a decrease in glucose levels was significantly correlated with copeptin increase (ρ = 0.53, p < 0.01). CONCLUSION: A similar course in plasma glucose was observed in the copeptin-stimulating test, i.e., after glucagon and arginine, while macimorelin had no effect on glucose and copeptin levels. We hypothesize that a drop in glucose levels observed upon glucagon and arginine might stimulate copeptin.
format Online
Article
Text
id pubmed-9345811
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-93458112022-08-04 The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study Atila, Cihan Monnerat, Sophie Urwyler, Sandrine Andrea Refardt, Julie Winzeler, Bettina Christ-Crain, Mirjam Pituitary Article PURPOSE: Non-osmotic stimulation tests using glucagon, arginine, or macimorelin were recently evaluated for their ability to assess posterior pituitary function. Glucagon and arginine, but not macimorelin, stimulated copeptin secretion (a surrogate marker of vasopressin) and, therefore, provide novel tests to assess the posterior pituitary. The exact underlying mechanism behind their stimulatory effect remains elusive. METHODS: This analysis combined data from three diagnostic studies conducted at the University Hospital Basel, Switzerland. In total, 80 healthy adults underwent the glucagon (n = 22), arginine (n = 30), or macimorelin (n = 28) stimulation tests. The primary objective was to investigate glucose course upon glucagon, arginine, and macimorelin stimulation tests and its effect on plasma copeptin release. RESULTS: Upon glucagon stimulation, the median [IQR] glucose level at baseline was 5.0 [4.6, 5.2] mmol/l, peaked at 8.1 [7.2, 9.4] mmol/l after 30 min and decreased to a minimum of 3.8 [3.5, 4.5] mmol/l after 120 min. The median copeptin increase upon glucagon stimulation was 7.7 [2.6, 28.0] pmol/l. Upon arginine, the glucose level at baseline was 4.9 [4.8, 5.5] mmol/l, peaked at 6.0 [5.2, 6.4] mmol/l after 30 min and decreased to a minimum of 4.3 [3.8, 4.8] mmol/l after 60 min. The median copeptin increase upon arginine stimulation was 4.5 [2.9, 7.5] pmol/l. Upon macimorelin, glucose levels showed no notable dynamics over the 120 min, and no major change in copeptin was observed. In the pooled dataset, a decrease in glucose levels was significantly correlated with copeptin increase (ρ = 0.53, p < 0.01). CONCLUSION: A similar course in plasma glucose was observed in the copeptin-stimulating test, i.e., after glucagon and arginine, while macimorelin had no effect on glucose and copeptin levels. We hypothesize that a drop in glucose levels observed upon glucagon and arginine might stimulate copeptin. Springer US 2022-06-20 2022 /pmc/articles/PMC9345811/ /pubmed/35723775 http://dx.doi.org/10.1007/s11102-022-01240-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Atila, Cihan
Monnerat, Sophie
Urwyler, Sandrine Andrea
Refardt, Julie
Winzeler, Bettina
Christ-Crain, Mirjam
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
title The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
title_full The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
title_fullStr The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
title_full_unstemmed The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
title_short The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: Data from: Glucacop, Macicop, and CARGO study
title_sort effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults: data from: glucacop, macicop, and cargo study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345811/
https://www.ncbi.nlm.nih.gov/pubmed/35723775
http://dx.doi.org/10.1007/s11102-022-01240-0
work_keys_str_mv AT atilacihan theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT monneratsophie theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT urwylersandrineandrea theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT refardtjulie theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT winzelerbettina theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT christcrainmirjam theeffectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT atilacihan effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT monneratsophie effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT urwylersandrineandrea effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT refardtjulie effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT winzelerbettina effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy
AT christcrainmirjam effectofglucosedynamicsonplasmacopeptinlevelsuponglucagonarginineandmacimorelinstimulationinhealthyadultsdatafromglucacopmacicopandcargostudy